Catalyst Edge · Scanner · Tickers · REGN
CATALYST DOSSIER · UPDATED 2026-11-03

$REGN

biotech · convergence -9 · conviction WATCH
Convergence Score
-9
Conviction
WATCH
Signals Firing
10
Track Record
5/5
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $REGN?

REGN -9 WATCH biotech

Quantitative

  • Net Income (CY2026Q2): $1.30B (-6.8% YoY)

Catalysts

  • Deal terms: earnout 2026-09-30
  • Deal terms: earnout 2026-09-30
  • Clinical trial milestone: Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Clinical trial milestone: Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Risks

  • Insider planned sale (Form 144): <b>Filed:</b> 2026-11-02 <b>AccNo:</b> 0001950047-26-010543 <b>Size:</b> 10 KB 2026-11-02
  • Insider planned sale (Form 144): <b>Filed:</b> 2026-11-02 <b>AccNo:</b> 0001969223-26-001114 <b>Size:</b> 4 KB 2026-11-02

Bear case

  • Squeeze unwind: Short interest can compress before retail catches the move — entry timing critical

Sympathy basket (cerebro)

  • TAP via staples r=-0.90 divergent (score 9)
  • UTZ via staples r=-0.90 divergent (score 5)
  • VTEX via tech r=+0.88 sympathetic (score 17)
  • PCOR via tech r=+0.88 sympathetic (score 16)
  • MRVL via semis r=+0.80 sympathetic (score 30)
  • AMD via semis r=+0.80 sympathetic (score 9)

Signals Firing

finra_shortclinicalfda_appmacroorphan_leanoge_execcontractsec_fdaauto_macro_adp_payrollsauto_macro_durable_goods
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Pick Track Record

DateListNext-day max runNext-day closeHit +2%?
2026-10-30sec_top_gappers+5.0%+3.6%✓ hit
2026-10-30sec_top_moat_emerging+5.0%+3.6%✓ hit
2026-09-30sec_clean_gappers+2.5%-3.1%✓ hit
2026-09-30sec_top_gappers+2.5%-3.1%✓ hit
2026-09-30sec_top_moat_emerging+2.5%-3.1%✓ hit
Lifetime: 5/5 wins · hit-rate 100.0% on +2% intraday

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for REGN. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 44.0% of the time across 414 tracked calls. Baseline for everything else: 38.4%. That is a +5.6 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

30 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →